These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16730390)

  • 21. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
    Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
    J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
    Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
    J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional characterization of the modified melanocortin peptides responsible for ligand selectivity at the human melanocortin receptors.
    Chen M; Georgeson KE; Harmon CM; Haskell-Luevano C; Yang Y
    Peptides; 2006 Nov; 27(11):2836-45. PubMed ID: 16730390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of novel melanotropin agonists and antagonists with high potency and selectivity for human melanocortin receptors.
    Cai M; Mayorov AV; Ying J; Stankova M; Trivedi D; Cabello C; Hruby VJ
    Peptides; 2005 Aug; 26(8):1481-5. PubMed ID: 15876475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feeding effects of melanocortin ligands--a historical perspective.
    Irani BG; Haskell-Luevano C
    Peptides; 2005 Oct; 26(10):1788-99. PubMed ID: 16046247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular biology and physiology of the melanocortin system in fish: a review.
    Metz JR; Peters JJ; Flik G
    Gen Comp Endocrinol; 2006 Sep; 148(2):150-62. PubMed ID: 16620815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting melanocortin receptors as a novel strategy to control inflammation.
    Catania A; Gatti S; Colombo G; Lipton JM
    Pharmacol Rev; 2004 Mar; 56(1):1-29. PubMed ID: 15001661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies.
    Holder JR; Haskell-Luevano C
    Med Res Rev; 2004 May; 24(3):325-56. PubMed ID: 14994367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New ligands for melanocortin receptors.
    Kaelin CB; Candille SI; Yu B; Jackson P; Thompson DA; Nix MA; Binkley J; Millhauser GL; Barsh GS
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S19-27. PubMed ID: 19136986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the physiological functions of the melanocortin system.
    Cone RD
    Endocr Rev; 2006 Dec; 27(7):736-49. PubMed ID: 17077189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observations on the ligand selectivity of the melanocortin 2 receptor.
    Veo K; Reinick C; Liang L; Moser E; Angleson JK; Dores RM
    Gen Comp Endocrinol; 2011 May; 172(1):3-9. PubMed ID: 21501611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The melanocortin system in leukocyte biology.
    Catania A
    J Leukoc Biol; 2007 Feb; 81(2):383-92. PubMed ID: 17041004
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.